- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Gaithersburg Today
By the People, for the People
Quantitative Investment Management Buys Stake in GeneDx
Hedge fund takes position in genetic testing company GeneDx
Mar. 13, 2026 at 10:40am
Got story updates? Submit your updates here. ›
Quantitative Investment Management LLC, a hedge fund, has purchased a new position in GeneDx Holdings Corp. (NASDAQ:WGS), a clinical diagnostics company specializing in genetic and genomic testing. The fund purchased 15,071 shares of GeneDx's stock, valued at approximately $1.62 million, representing around 0.05% ownership of the company.
Why it matters
This investment by Quantitative Investment Management, a prominent hedge fund, signals confidence in GeneDx's business model and growth potential within the genetic testing industry. GeneDx offers a range of genetic and genomic testing services to help diagnose rare and inherited disorders, which is a rapidly expanding field of medicine.
The details
According to a recent SEC filing, Quantitative Investment Management purchased the 15,071 shares of GeneDx during the third quarter. This represents the fund's first position in the company. GeneDx, founded in 2000 and based in Gaithersburg, Maryland, provides a broad portfolio of genetic testing services to clinicians to help diagnose a wide range of conditions, from rare pediatric diseases to hereditary cancer syndromes.
- Quantitative Investment Management purchased the GeneDx shares during the third quarter of the year.
The players
Quantitative Investment Management LLC
A hedge fund that has purchased a new position in GeneDx Holdings Corp.
GeneDx Holdings Corp.
A clinical diagnostics company specializing in comprehensive genetic and genomic testing for rare and inherited disorders.
The takeaway
This investment by a prominent hedge fund underscores the growing importance and potential of genetic testing companies like GeneDx in the healthcare industry. As the field of genetic medicine continues to advance, companies that can provide comprehensive and accurate genetic testing services are likely to see increased demand for their products and services.
